S.C Ovidius Clinical Hospital S.R.L

Ovidiu

2 studies enrolling now · 2 studies all time

What they study most

Extensive Stage Small Cell Lung Cancer (ES-SCLC), Gastric Cancer, Gastroesophageal Junction Cancer

Studies at this site

• Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer — Recruiting now
• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now